Part 1. Overview Information

Key Dates

All applications are due by 5:00 PM local time of applicant organization. 

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

It is critical that applicants follow the instructions in the Research (R) Instructions in the How to Apply - Application Guide, except where instructed to do otherwise (in this NOFO or in a Notice from NIH Guide for Grants and Contracts).

Conformance to all requirements (both in the Application Guide and the NOFO) is required and strictly enforced. Applicants must read and follow all application instructions in the Application Guide as well as any program-specific instructions noted in Section IV. When the program-specific instructions deviate from those in the Application Guide, follow the program-specific instructions.

Applications that do not comply with these instructions may be delayed or not accepted for review.

There are several options available to submit your application through Grants.gov to NIH and Department of Health and Human Services partners. You must use one of these submission options to access the application forms for this opportunity.

1. Use the NIH ASSIST system to prepare, submit and track your application online.
2. Use an institutional system-to-system (S2S) solution to prepare and submit your application to Grants.gov and eRA Commons to track your application. Check with your institutional officials regarding availability.
   
   
3. Use Grants.gov Workspace to prepare and submit your application and eRA Commons to track your application.



Table of Contents
Part 1. Overview Information
Key Dates
Part 2. Full Text of Announcement
Section I. Notice of Funding Opportunity Description
Section II. Award Information
Section III. Eligibility Information
Section IV. Application and Submission Information
Section V. Application Review Information
Section VI. Award Administration Information
Section VII. Agency Contacts
Section VIII. Other Information

Part 2. Full Text of Announcement

Section I. Notice of Funding Opportunity Description

The National Institutes of Health (NIH) is continuing to make a special effort to stimulate research at educational institutions that provide baccalaureate and/or advanced degrees for a significant number of the Nation's research institutions that have not been major recipients of NIH support. Since Fiscal Year (FY) 1985 Congressional appropriations for the NIH have included funds for this initiative, known as the Academic Research Enhancement Award (AREA) program that was intended to focus on undergraduate institutions (PAR-25-134). To complement the AREA program, this notice of funding opportunity (NOFO) specifically supports eligible health professional schools and graduate schools, along with undergraduate schools to provide research experiences to health professional, undergraduate and/or graduate students pursuing biomedical or behavioral research.

The three objectives of this NOFO are to: (1) provide support for meritorious research; (2) strengthen the research environment at these institutions; and (3) give health professional, undergraduate and/or graduate students an opportunity to gain significant biomedical research experience through active involvement in the research. For the purposes of this NOFO, health professional schools and colleges are accredited institutions that provide education and training leading to a health professional degree, including but not limited to: BSN, MSN, DNP, MD, DDS, DMD, DO, PharmD, DVM, OD, DPT, DC, ND, DPM, MOT, OTD, MS-SLP, CScD, SLPD, AuD, MSPO, MSAT, and MPH. Eligible health professional schools/colleges may include schools or colleges of nursing, medicine, dentistry, osteopathy, pharmacy, veterinary medicine, public health, optometry, allied health, chiropractics, naturopathy, podiatry, rehabilitation medicine, physical therapy, orthotics & prosthetics, kinesiology, occupational therapy and psychology. Accreditation must be provided by a body approved for such purpose by the Secretary of Education.

The REAP program will enable qualified scientists to receive support for small-scale research projects. It is anticipated that investigators supported under the REAP program will benefit from the opportunity to conduct independent research; that the recipient institution will benefit from a research environment strengthened through REAP grants; and that students at recipient institutions will benefit from exposure to and participation in scientific research in the biomedical sciences and be inspired to consider careers in biomedical research. The REAP NOFO emphasizes the engagement and inclusion of health professional, undergraduates and/or graduate students in research. Since diversity strengthens the research environment, REAP projects are encouraged to recruit and include students from diverse backgrounds, including those from groups underrepresented in the biomedical research workforce. (See NOT-OD-20-031)

The research project must involve health professional, undergraduate and/or graduate students and the research team must be composed primarily of health professional, undergraduate and/or graduate students. Student involvement in the research project may include participation in the design of experiments and controls, collection and analysis of data, execution and troubleshooting of experiments, participation in research meetings, and discussion of future directions. When applicable, it is highly desirable that student participation also include presentation at local and/or national meetings, publication of journal articles, and collaborative interactions. The REAP is a research grant program, not a training or fellowship program. As such, applications should not include training plans such as didactic training or non-research activities relating to professional development. This NOFO does not provide support for research at undergraduate-focused institutions, and investigators from those institutions should apply to PAR-25-134 Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 Clinical Trial Not Allowed). Additional information on R15 programs can be found at: NIH Research Enhancement Award (R15).

A REAP application submitted to this NOFO may include other investigators, such as collaborators or consultants, or other individuals such as high school students, post baccalaureate participants, postdoctoral fellows, or clinical fellows. However, the involvement of such individuals does not fulfill the goal of engaging health professional, undergraduate and/or graduate students in eligible environments in research.

This NOFO will support basic and/or human subjects research but will NOT support research meeting the NIH definition of a clinical trial. Applicants are strongly encouraged to refer to NIH guidance on clinical trials (Clinical Trial Requirements for Grants and Contracts) or consult with NIH staff before selecting a NOFO. Investigators who intended to propose a clinical trial should apply to the Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Required) funding opportunity (PAR-21-357).

In addition, applicants are encouraged to consult the Frequently Asked Questions website and the NIH Research Enhancement Award R15 website for more information about this program.

Pre-consultation

Participating NIH Institutes and Centers are listed on the first page of this announcement ("Components of Participating Organizations"). For additional scientific program information and for pre-application guidance, applicants are encouraged to contact the person listed for the participating NIH IC(s) with research interests relevant to the applicant's proposed topic. Consultation with relevant NIH staff prior to the application due date is strongly encouraged for new and resubmission applications. See Section VII. for contact information.

Institute/Center Specific Interests

National Heart, Lung, and Blood Institute (NHLBI)

The NHLBI supports basic and clinical research pertaining to the structure, function, and diseases of the cardiovascular system, lungs, blood and blood vessels, and sleep disorders. NHLBI supports clinical trial research that is mechanistic and/or efficacy focused, including behavioral, pharmacotherapeutic, device-based, and other intervention approaches. The NHLBI also supports research in stem cell biology and transplantation, transfusion medicine, and blood resources. The NHLBI carries out its mission through a number of research programs that provide support for projects ranging from studies at the molecular level to whole body studies in man and animals. Examples of research areas supported by the NHLBI include atherosclerosis, hypertension, cerebrovascular disease (directed at the dependent variable of blood, heart, or blood vessel), coronary heart disease, peripheral vascular diseases, arrhythmias, heart failure, and shock, congenital and rheumatic heart diseases, cardiomyopathies and infections of the heart, circulatory assistance, lung cell and molecular biology, chronic obstructive lung diseases, pediatric pulmonary diseases, cystic fibrosis, sleep-disordered breathing, asthma, fibrotic and immunologic lung diseases, acute respiratory failure, pulmonary vascular diseases, HIV-associated lung disorders and bone marrow suppression, bleeding and clotting disorders, disorders of the red blood cell such as sickle cell disease and Cooley's anemia, bone marrow failure syndromes, and blood resources.

National Human Genome Research Institute (NHGRI)

NHGRI supports the development of resources, approaches, and technologies that will accelerate genomic research on the structure of genomes, the biology of genomes, and the biology of disease; that will use genomics to advance the science of medicine; and that will incorporate genomics to improve the effectiveness of healthcare. NHGRI also supports genomic research in several cross-cutting areas, including the ethical, legal and societal implications of genomics and genetics research, bioinformatics, technology development, and research training and career development. In general, NHGRI supports studies that provide generalizable methods and knowledge. Applications for studies relevant only to a particular disease or organ system should be directed to the appropriate Institute or Center. NHGRI strongly encourages potential applicants to reach out to the listed scientific contact in the early stages of developing an application.

National Institute on Aging (NIA)

NIA will accept applications for research projects in areas within the Institute's mission that includes genetic, biological, behavior, social, and economic research on aging. In addition, NIA encourages applications on Alzheimer’s Disease (AD) and AD Related Dementias (ADRD). The NIA website (https://www.nia.nih.gov/) provides additional information. about the Institute mission and areas of research interest. For additional scientific program information and for pre-application guidance, a potential applicant is encouraged to contact the NIA Program Director (link) whose portfolio covers the scientific topic of interest.

National Institute of Alcohol Abuse and Alcoholism (NIAAA)

NIAAA supports basic, translational, and clinical research on the causes, consequences, prevention, diagnosis, progression, and treatment of alcohol-related problems across the lifespan. NIAAA encourages meritorious alcohol research projects in the broad areas of neuroscience and behavior, organ damage and other health effects, epidemiology and prevention, and treatment and recovery. Investigators who conduct original and innovative basic biomedical, social, behavioral, clinical, or population-based research directed toward eliminating health disparities are invited to apply to this FOA. Projects may include a focus on addressing disparities in disparity populations as a whole, a single health disparity population, or a subgroup within a health disparity population. Projects addressing the improvement of health in racial/ethnic minority populations (without a specific emphasis on disparities relative to other groups) are also accepted under this announcement. More information about NIAAA’s mission and research priorities is available in the NIAAA Strategic Plan at https://www.niaaa.nih.gov/strategic-plan. For specific programmatic questions, please contact the NIAAA point-of-contact listed in this FOA.

National Institute of Allergy and Infectious Diseases (NIAID)
NIAID supports basic and applied research to better understand, treat, and prevent infectious, immunologic, and allergic diseases, with the goal of developing new therapies, vaccines, diagnostic tests, and other technologies. Research areas include microbiology and infectious diseases, AIDS and AIDS -related research, immunology, allergy, transplantation, radiation medical countermeasures,and biodefense.

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

NIAMS supports research into the causes, treatment, and prevention of arthritis and musculoskeletal and skin diseases; the training of basic and clinical scientists to carry out this research; and the dissemination of information on research progress in these diseases. NIAMS also conducts and supports basic research on the normal structure and function of bones, joints, muscles, and skin. Basic research involves a wide variety of scientific disciplines, including immunology, genetics, molecular biology, structural biology, biochemistry, physiology, virology, and pharmacology. Clinical research includes rheumatology, orthopedics, dermatology, metabolic bone diseases, heritable disorders of bone and cartilage, inherited and inflammatory muscle diseases, and sports and rehabilitation medicine.

NIAMS will accept applications for research projects in areas within the Institute's mission. Applications from institutions serving underrepresented groups and institutions with well-developed, documented programs promoting diversity in the biomedical, behavioral, and clinical research workforce are strongly encouraged to apply. The NIAMS website (https://www.niams.nih.gov/) provides information about the institute mission and areas of research interest (https://www.niams.nih.gov/about-niams/strategic-plan-fiscal-years-2020-2024). For additional scientific program information and for pre-application guidance, potential applicants are encouraged to contact the NIAMS Extramural Research Program Staff whose portfolio covers the scientific topic of interest (https://www.niams.nih.gov/grants-funding/funding-opportunities/supported-scientific-areas).

National Institute of Biomedical Imaging and Bioengineering (NIBIB)
The mission of the National Institute of Biomedical Imaging and Bioengineering (NIBIB) is to improve human health by supporting the development of cutting-edge technologies and computational methods in Biomedical imaging and Bioengineering. NIBIB-funded innovations have broad impact and fundamentally change our ability to prevent, diagnose, and treat human disease. Under this FOA, NIBIB will fund research projects that can be generalized to multiple conditions and physiological contexts and that fall under one or more of its Scientific Program Areas.

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

The NICHD supports biological, behavioral, and clinical research related to conception and pregnancy, normal and abnormal development in childhood, reproductive health, population dynamics across the lifespan, and rehabilitation medicine. https://www.nichd.nih.gov/grants-funding/opportunities-mechanisms/areas-research/Pages/default.aspx.

Research projects considered by funding by NICHD must fall within the scientific missions of the twelve Scientific Branches of the NICHD Division of Extramural Research (DER) or the National Center for Medical Rehabilitation Research (NCMRR). Information about those scientific missions and program staff contacts may be found on the web pages for the DER scientific branches at: http://www.nichd.nih.gov/about/org/der/branches/Pages/index.aspx and the NCMRR at: http://www.nichd.nih.gov/about/org/ncmrr/Pages/overview.aspx. Potential applicants are strongly encouraged to read these webpages for any updates in response to recent scientific advances or emerging public health topics.

NICHD encourages applications that address its extramural program priorities and will consider how well research projects align with one or more of those priorities when making award decisions. A detailed list of NICHD high priority research areas may be found at https://www.nichd.nih.gov/grants-funding/opportunities-mechanisms/areas-research/Pages/priorities.asp.

National Institute on Deafness and other Communication Disorders (NIDCD)

NIDCD supports applications that proposes research projects in the normal and disordered processes of hearing, balance, taste, smell, voice, speech, and language. Applicants are strongly encouraged to learn more about NIDCD research areas at https://www.nidcd.nih.gov/research/extramural. 

 National Institute of Dental and CraniofacialResearch (NIDCR)

NIDCR supports research concerning the etiology, epidemiology, prevention, diagnosis, and treatment of dental, oral and craniofacial disorders and diseases. In this context, the NIDCR emphasizes research on caries and periodontal diseases; oral infections (viral, fungal, and bacterial) host-responses to oral infections, (e.g., innate and adaptive immune responses), biofilms and microbial ecology, genomics and proteomics; oral aspects of AIDS/HIV infection; head and neck cancers; craniofacial development, physiology and malformations; orofacial pain and other oral sensory and motor dysfunctions; salivary glands and disorders such as Sjögren's disease; temporomandibular joint disorders; and restoration and regeneration of dental, oral and craniofacial structures.

National Institute of Drug Abuse (NIDA)

NIDA is the lead federal agency supporting scientific research on drug use and its consequences. Our mission is to advance science on the causes and consequences of drug use and addiction and to apply that knowledge to improve individual and public health. Applications considered for funding by the NIDA should address critical issues of neuroscience, genetics, behavior, prevention, treatment, epidemiology, etiology, health services, health disparities, data science, medications development, HIV/AIDS, and co-occurring opportunistic infections (e.g., hepatitis C) in substance using populations, or other research areas relevant to drug use and addiction. NIDA priorities are further described in the NIDA Strategic Plan (see https://www.drugabuse.gov/about-nida/strategic-plan/executive-summary) and on the NIDA Research Programs and Activities (see https://www.drugabuse.gov/research/nida-research-programs-activities). Applicants are encouraged to contact a program official to discuss the proposed application.

National Institute of Environmental Health Sciences (NIEHS)

NIEHS supports a variety of scientific disciplines, including basic, mechanistic, clinical, epidemiological, computational, engineering, and/or health risk communication approaches that can be used to advance the NIEHS Strategic Plan. Applications submitted to this NOFO must have a research focus on exposure-health related responses from environmental agents within the mission interest of the NIEHS (e.g., industrial chemicals or manufacturing byproducts, metals, pesticides, herbicides, air pollutants and other inhaled toxicants, particulates or fibers, fungal, and bacterial or biologically derived toxins). Agents that are considered within the primary mission responsibility of other NIH Institutes and Centers include, but are not limited to: alcohol; chemotherapeutic agents; radiation that is not a result of an ambient environmental exposure; smoking, except when considered as a prenatal exposure or secondary smoke exposure in the indoor environment (particularly in children); drugs of abuse; pharmaceuticals; dietary nutrients; and infectious or parasitic agents. Applications that focus entirely, or primarily, on these exposure factors will not be considered for support by NIEHS.

National Institute for Mental Health (NIMH)

The mission of the National Institute of Mental Health (NIMH) is to transform the understanding and treatment of mental illnesses through basic and clinical research, paving the way for prevention, recovery, and cure. Applications considered for funding by the NIMH must fall within the areas of priority detailed in the NIMH Strategic Plan and the NIMH Strategic Research Priorities. Applicants are strongly encouraged to contact the person listed under Agency Contacts (Section VII) prior to submission.

The National Institute of Neurological Disorders and Stroke (NINDS)

NINDS seeks fundamental knowledge about the brain and nervous system and to use that knowledge to reduce the burden of neurological disease. NINDS supports basic, translational and clinical research within specifically defined areas of neuroscience. Research projects considered for funding by NINDS must fall within the scientific research mission of the Institute. Applicants are strongly encouraged to contact the person listed under Agency Contacts (Section VII) early in the application preparation process to confirm the relevance of the proposed research to the NINDS mission and for preapplication guidance.

National Institute of Nursing Research (NINR)

The National Institute of Nursing Research (NINR) supports research that builds the scientific foundation for nursing practice and policy across clinical and community settings, and advances the prevention, detection, and management of disease and disability. Drawing on nursing’s holistic perspective, NINR funds research that integrates factors at multiple levels, including social determinants of health, to identify their role in health, health improvement, and health inequities. NINR promotes research that improves the health of individuals, families, and populations in a variety of settings, translating science in order to maximize the impact of findings on practice and policy. Advancing health equity is an area of high priority.

National Center for Complementary and Integrative Health (NCCIH)

The mission of NCCIH is to determine, through rigorous scientific investigation, the usefulness and safety of complementary health approaches, and their roles in improving health and healthcare. NCCIH’s strategic plan includes five major objectives: 1) Advance fundamental science and methods development; 2) Advance research on the whole person and on the integration of complementary and conventional care; 3) Foster research on health promotion and restoration, resilience, disease prevention, and symptom management; 4) Enhance the complementary and integrative health research workforce; and 5) Provide objective evidence-based information on complementary and integrative health interventions. In pursuit of these objectives, NCCIH supports research on complementary and integrative health approaches with physical and/or psychological therapeutic inputs (often called mind and body approaches); research on nutritional interventions including natural products; and studies of “real world” patterns and outcomes of use of complementary therapies. Studies in response to this FOA may range from basic, through translational, epidemiological, health services, and other human subjects research, but may not propose a clinical trial. Investigators are strongly encouraged to discuss their concepts with NCCIH program staff prior to applying.

Office of Research Infrastructure Programs (ORIP)
ORIP’s mission is to support research infrastructure and related programs, including research resources centers that provide animal models used to study the causes, treatment, and prevention of diseases. These resources benefit researchers supported by many NIH Institutes, Centers, and Offices (ICOs). ORIP also provides specialized biomedical research training for veterinary scientists.

ORIP will accept applications from eligible health professional schools, with preference given to colleges of veterinary medicine, proposing comparative studies of a wide range of biological models to improve their value in translational research. Applications must not be categorical in nature (i.e., not organ specific or restricted to a single disease) and should be trans-NIH in scope, (i.e., encompassing the mission of two or more NIH ICOs). Projects also need to be responsive to both the mission of the NIH and of ORIP, as described in the ORIP 2021-2025 Strategic Plan. Applicants are strongly encouraged to reach out to ORIPs’ contact person prior to submission.

See Section VIII. Other Information for award authorities and regulations.

Section II. Award Information

NIH grants policies as described in the NIH Grants Policy Statement will apply to the applications submitted and awards made from this NOFO.

Section III. Eligibility Information

1. Eligible Applicants

Higher Education Institutions

• Public/State Controlled Institutions of Higher Education
• Private Institutions of Higher Education

The following types of Higher Education Institutions are always encouraged to apply for NIH support as Public or Private Institutions of Higher Education:

• Hispanic-serving Institutions
• Historically Black Colleges and Universities (HBCUs)
• Tribally Controlled Colleges and Universities (TCCUs)
• Alaska Native and Native Hawaiian Serving Institutions
• Asian American Native American Pacific Islander Serving Institutions (AANAPISIs)

Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.

In addition, all organizations must meet the following criteria at the time of submission:

• The applicant organization must be an accredited public or non-profit private school that grants baccalaureate or advanced degrees in health professions (see section below for more details) or biomedical and behavioral sciences. The application must be submitted by the eligible organization with a unique entity identifier (UEI) and a unique NIH eRA Institutional Profile File (IPF) number.
• At the time of application submission, all components of the institution combined must not have received support from the NIH totaling more than $6 million per year (in both direct and F&A/indirect costs) in 4 of the last 7 years. A year is defined as a federal fiscal year: from October 1 through September 30. For institutions composed of multiple schools and colleges, the $6 million funding limit is based on the amount of NIH funding received by all of the schools and colleges within the institution as a whole. Note that all activity codes are included in this calculation except the following: C06, S10, and all activity codes starting with a G.
• For this NOFO: Only eligible Health Professional or Graduate Institutions may apply
• For this NOFO: Non-health professional or non-graduate academic institutions are not eligible to apply
• For the purposes of this NOFO, a graduate school offers advanced degrees, beyond the undergraduate level, in an academic discipline including M.A., M.S., and Ph.D. degrees.
• Health professional schools and colleges are accredited institutions that provide education and training leading to a health professional degree, including but not limited to: BSN, MSN, DNP, MD, DDS, DMD, DO, PharmD, DVM, OD, DPT, DC, ND, DPM, MOT, OTD,  MS-SLP, CScD, SLPD, AuD, MSPO, MSAT, and MPH.
• Eligible health professional schools/colleges may include schools or colleges of nursing, medicine, dentistry, osteopathy, pharmacy, veterinary medicine, public health, optometry, allied health, chiropractic, naturopathy, podiatry, rehabilitation medicine, physical therapy, orthotics & prosthetics, kinesiology, occupational therapy and psychology. Accreditation must be provided by a body approved for such purpose by the Secretary of Education.
• For institutions with multiple campuses, eligibility can be considered for each individual campus (e.g., main, satellite, etc.) only if a unique entity identifier (UEI) and NIH IPF number are established for each campus. For institutions that use one UEI or NIH IPF number for all campuses, eligibility is determined for all campuses (e.g., main, satellite, etc.) together.

Additional Eligibility Guidance

A signed letter is required from the Provost or similar official with institution-wide responsibility verifying the eligibility of the applicant institution at the time of application submission according to the eligibility criteria indicated above. See the application instructions for "Other Attachments" on the SF424(R&R) Other Project Information form in Section IV.2 Instructions for Application Submission. Final eligibility will be validated by NIH prior to award.

To assist in determining eligibility, organizations are encouraged to use the NIH RePORT website under NIH Awards by Location & Organization (http://projectreporter.nih.gov/reporter.cfm).

A REAP grant is permitted to have a subcontract to a non-REAP-eligible institution. However, applicants should keep the goals of the REAP program in mind when preparing the application, which include strengthening the research environment of eligible institutions and engaging students from eligible institutions in research. It is expected that the majority of the research will be directed by the PD(s)/PI(s) at the recipient institution.

Undergraduate-focused institutions with undergraduate enrollment greater than graduate enrollment should apply to PAR-25-134, Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15-Clinical Trial Not Allowed) or to PAR-25-148, Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15- Clinical Trial Required).

Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.

Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Applicant Organizations

Applicant organizations must complete and maintain the following registrations as described in the How to Apply- Application Guide to be eligible to apply for or receive an award. All registrations must be completed prior to the application being submitted. Registration can take 6 weeks or more, so applicants should begin the registration process as soon as possible. Failure to complete registrations in advance of a due date is not a valid reason for a late submission, please reference the NIH Grants Policy Statement Section 2.3.9.2 Electronically Submitted Applications for additional information.

• System for Award Management (SAM) – Applicants must complete and maintain an active registration, which requires renewal at least annually. The renewal process may require as much time as the initial registration. SAM registration includes the assignment of a Commercial and Government Entity (CAGE) Code for domestic organizations which have not already been assigned a CAGE Code.
  • NATO Commercial and Government Entity (NCAGE) Code – Foreign organizations must obtain an NCAGE code (in lieu of a CAGE code) in order to register in SAM.
  • Unique Entity Identifier (UEI) - A UEI is issued as part of the SAM.gov registration process. The same UEI must be used for all registrations, as well as on the grant application.
• eRA Commons - Once the unique organization identifier is established, organizations can register with eRA Commons in tandem with completing their Grants.gov registrations; all registrations must be in place by time of submission. eRA Commons requires organizations to identify at least one Signing Official (SO) and at least one Program Director/Principal Investigator (PD/PI) account in order to submit an application.
• Grants.gov – Applicants must have an active SAM registration in order to complete the Grants.gov registration.

Program Directors/Principal Investigators (PD(s)/PI(s))

All PD(s)/PI(s) must have an eRA Commons account.  PD(s)/PI(s) should work with their organizational officials to either create a new account or to affiliate their existing account with the applicant organization in eRA Commons. If the PD/PI is also the organizational Signing Official, they must have two distinct eRA Commons accounts, one for each role. Obtaining an eRA Commons account can take up to 2 weeks.

Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) is invited to work with their organization to develop an application for support. Individuals from diverse backgrounds, including underrepresented racial and ethnic groups, individuals with disabilities, and women are always encouraged to apply for NIH support. See, Reminder: Notice of NIH's Encouragement of Applications Supporting Individuals from Underrepresented Ethnic and Racial Groups as well as Individuals with Disabilities, NOT-OD-22-019, and Notice of NIH's Interest in Diversity, NOT-OD-20-031.

For institutions/organizations proposing multiple PDs/PIs, visit the Multiple Program Director/Principal Investigator Policy and submission details in the Senior/Key Person Profile (Expanded) Component of the How to Apply-Application Guide.

To be eligible for a REAP grant, the PD(s)/PI(s) must meet the following additional criteria:

• Each PD(s)/PI(s) must have a primary appointment at a health professional or graduate school or college within the applicant institution, as defined in "Eligible Institutions," above. If proposing multiple PD(s)/PI(s), each PD/PI must be at a REAP-eligible institution.
• Each PD(s)/PI(s) may not be the PD(s)/PI(s) of an active NIH research grant, including another R15 grant, at the time of award of a REAP grant, although they may be one of the Key Personnel for an active NIH grant held by another PD/PI.
• Each PD(s)/PI(s) may not be awarded more than one R15 grant at a time, although they may hold successive New or Renewal grants.

2. Cost Sharing

This NOFO does not require cost sharing as defined in the NIH Grants Policy Statement Section 1.2 Definition of Terms.

3. Additional Information on Eligibility

Number of Applications

Applicant organizations may submit more than one application, provided that each application is scientifically distinct.

The NIH will not accept duplicate or highly overlapping applications under review at the same time, per NIH Grants Policy Statement Section 2.3.7.4 Submission of Resubmission Application. This means that the NIH will not accept:

• A new (A0) application that is submitted before issuance of the summary statement from the review of an overlapping new (A0) or resubmission (A1) application.
• A resubmission (A1) application that is submitted before issuance of the summary statement from the review of the previous new (A0) application.
• An application that has substantial overlap with another application pending appeal of initial peer review (see NIH Grants Policy Statement 2.3.9.4 Similar, Essentially Identical, or Identical Applications).

Section IV. Application and Submission Information

1. Requesting an Application Package

The application forms package specific to this opportunity must be accessed through ASSIST, Grants.gov Workspace or an institutional system-to-system solution. Links to apply using ASSIST or Grants.gov Workspace are available in Part 1 of this NOFO. See your administrative office for instructions if you plan to use an institutional system-to-system solution.

2. Content and Form of Application Submission

It is critical that applicants follow the instructions in the Research (R) Instructions in the How to Apply - Application Guide except where instructed in this notice of funding opportunity to do otherwise. Conformance to the requirements in the Application Guide is required and strictly enforced. Applications that are out of compliance with these instructions may be delayed or not accepted for review.

Page Limitations

All page limitations described in the How to Apply- Application Guide and the Table of Page Limits must be followed.

The following section supplements the instructions found in the How to Apply- Application Guide and should be used for preparing an application to this NOFO.

SF424(R&R) Cover

All instructions in the How to Apply - Application Guide must be followed.

SF424(R&R) Project/Performance Site Locations

All instructions in the How to Apply- Application Guide must be followed.

SF424(R&R) Other Project Information

All instructions in the How to Apply- Application Guide must be followed.

Facilities & Other Resources: The following information should be included.

• A profile of the students of the applicant institution and any information or estimate of the number who have obtained a health professional, baccalaureate or advanced degree and gone on to obtain an academic or professional doctoral or other advanced degree in the health-related sciences during the last five years.
• Description of plan to enhance recruiting of women and individuals from groups traditionally under-represented in the biomedical, behavioral, and clinical research workforce as described in the NIH Notice of Interest in Diversity.
• Description of the special characteristics of the applicant institution that make it appropriate for a REAP grant awarded through this NOFO, where the goals of this NOFO are to: (1) provide support for meritorious research at health professional or graduate institution or institutional components; (2) strengthen the research environment at these institutions/components; and (3) give health professional, undergraduate and/or graduate students an opportunity to gain significant biomedical research experience through active involvement in the research.
• Description of the likely impact of a REAP grant on the PD(s)/PI(s).
• Description of the likely impact of a REAP grant on the research environment of the applicant institution.
• Description of the likely impact of the REAP grant on the ability of health professional, undergraduate and/or graduate students at the institution to gain experience conducting biomedical research.
• Provide a description of the resources of the recipient institution available for the proposed research (e.g., equipment, supplies, laboratory space, release time, matching funds, etc.).
• Although the majority of the research must be directed by the PD(s)/PI(s) and conducted at the applicant institution, limited use of special facilities or equipment at another institution is permitted. For any proposed research sites other than the applicant institution, provide a brief description of the resources and access students will need and have to these resources.

Other Attachments: The application must include a PDF-formatted letter named "ProvostLetter.pdf" (without quotation marks). For MPI applications a Provost signed letter is required from each involved institution. The letter must be signed by the Provost or similar official with institution-wide responsibility attesting to the following information:

• The eligible academic component(s) (i.e., the college/school level) must be a health professional or graduate school that awards health professional, baccalaureate or advanced degrees in biomedical and/or biobehavioral sciences.
• All components of the institution together have received support from the NIH totaling no more than $6 million per year (in both direct and F&A/indirect costs) in 4 of the last 7 years, as described in Section III, "Eligible Organization”.
• Validation that the PD(s)/PI(s) has (or in the case of a multiple PD/PI application that all PD(s)/PI(s) have) a primary appointment at the qualifying component (i.e., health professional or graduate school).

Applications that do not contain this signed letter will be withdrawn without review.

SF424(R&R) Senior/Key Person Profile

All instructions in the How to Apply- Application Guide must be followed.

Biographical Sketch: The PD(s)/PI(s) should include a summary of their previous and/or current experience supervising undergraduate and/or graduate students in research in the Personal Statement. The PD(s)/PI(s) should indicate which peer-reviewed publications or other research products involved undergraduate and/or graduate students under their supervision.

R&R or Modular Budget

All instructions in the SF424 (R&R) Application Guide must be followed.

Modular Budget (direct costs of $250,000 or less):

All instructions in the SF424 (R&R) Application Guide must be followed, with the following additional instructions:

Budget Period 1: Direct Costs

Direct Costs less Consortium F&A: Select the appropriate dollar amount from the drop-down list. This number must not exceed $250,000.

Budget Justification:

Personnel Justification: Since a primary objective of the REAP is to engage health professional, undergraduate and/or graduate students in meritorious research, the research team must be composed primarily of health professional, undergraduate and/or graduate students from the applicant institution/REAP-eligible component. Indicate aspects of the proposed research in which students will participate. If participating students have not yet been individually identified, the number and academic level of those to be involved should be provided. If there are any Collaborators or Consultants for the project, provide their names, organizational affiliations, and the services they will perform.

R&R Budget (direct costs of $250,001 to $375,000):

All instructions in the SF424 (R&R) Application Guide must be followed, with the following additional instructions:

Budget Period 1: Direct Costs

Total Direct Costs less Consortium F&A: This number must not exceed $375,000.

Budget Justification:

Personnel Justification: Since a primary objective of the REAP is to engage health professional, undergraduate and/or graduate students in meritorious research, the research team must be composed primarily of health professional, undergraduate and/or graduate students from the applicant institution/REAP-eligible component. Indicate aspects of the proposed research in which students will participate. If participating students have not yet been individually identified, the number and academic level of those to be involved should be provided. If there are any Collaborators or Consultants for the project, provide their names, organizational affiliations, and the services they will perform.

R&R Subaward Budget

All instructions in the How to Apply-Application Guide must be followed.

PHS 398 Cover Page Supplement

All instructions in the How to Apply- Application Guide must be followed.

PHS 398 Research Plan

All instructions in the How to Apply- Application Guide must be followed, with the following additional instructions:

Research Strategy: Describe how the proposed plan can achieve the specific aims using a research team composed primarily of health professional, undergraduate and/or graduate students. Describe how students will be engaged in and supervised in conducting hands-on, rigorous research. Describe how students will participate in research activities such as planning, execution, and/or analysis of the research. Describe any other plans for student involvement, such as presentation at local or national meetings, participation in publication of research findings and development of, or participation in, collaborative activities. Formal training plans (e.g., non-research activities, didactic training, seminars) should not be provided, although a brief description of activities related to enhancing students' research capabilities and progress (e.g., the use of individual development plans, etc.) is permitted.

Progress Report Publication List: For renewal applications, when listing publications, manuscripts accepted for publication, patents, and other printed materials that have resulted from the project, note which of these products have included the work of students conducting research supported by the REAP grant.

Resource Sharing Plan: Individuals are required to comply with the instructions for the Resource Sharing Plans as provided in the How to Apply- Application Guide.

Other Plan(s): 

All instructions in the How to Apply-Application Guide must be followed, with the following additional instructions:

• All applicants planning research (funded or conducted in whole or in part by NIH) that results in the generation of scientific data are required to comply with the instructions for the Data Management and Sharing Plan. All applications, regardless of the amount of direct costs requested for any one year, must address a Data Management and Sharing Plan.

Appendix: Only limited Appendix materials are allowed. Follow all instructions for the Appendix as described in the How to Apply- Application Guide.

• No publications or other material, with the exception of blank questionnaires or blank surveys, may be included in the Appendix.

PHS Human Subjects and Clinical Trials Information

When involving human subjects research, clinical research, and/or NIH-defined clinical trials (and when applicable, clinical trials research experience) follow all instructions for the PHS Human Subjects and Clinical Trials Information form in the How to Apply- Application Guide, with the following additional instructions:

If you answered “Yes” to the question “Are Human Subjects Involved?” on the R&R Other Project Information form, you must include at least one human subjects study record using the Study Record: PHS Human Subjects and Clinical Trials Information form or Delayed Onset Study record.

Study Record: PHS Human Subjects and Clinical Trials Information

All instructions in the How to Apply- Application Guide must be followed.

Delayed Onset Study

Note: Delayed onset does NOT apply to a study that can be described but will not start immediately (i.e., delayed start). All instructions in the SF424 (R&R) Application Guide must be followed.

PHS Assignment Request Form

All instructions in the How to Apply- Application Guide must be followed.

3. Unique Entity Identifier and System for Award Management (SAM)

See Part 2. Section III.1 for information regarding the requirement for obtaining a unique entity identifier and for completing and maintaining active registrations in System for Award Management (SAM), NATO Commercial and Government Entity (NCAGE) Code (if applicable), eRA Commons, and Grants.gov

4. Submission Dates and Times

Part I. contains information about Key Dates and times. Applicants are encouraged to submit applications before the due date to ensure they have time to make any application corrections that might be necessary for successful submission. When a submission date falls on a weekend or Federal holiday, the application deadline is automatically extended to the next business day.

Organizations must submit applications to Grants.gov (the online portal to find and apply for grants across all Federal agencies). Applicants must then complete the submission process by tracking the status of the application in the eRA Commons, NIH’s electronic system for grants administration. NIH and Grants.gov systems check the application against many of the application instructions upon submission. Errors must be corrected and a changed/corrected application must be submitted to Grants.gov on or before the application due date and time.  If a Changed/Corrected application is submitted after the deadline, the application will be considered late. Applications that miss the due date and time are subjected to the NIH Grants Policy Statement Section 2.3.9.2 Electronically Submitted Applications.

Applicants are responsible for viewing their application before the due date in the eRA Commons to ensure accurate and successful submission.

Information on the submission process and a definition of on-time submission are provided in the How to Apply-Application Guide.

5. Intergovernmental Review (E.O. 12372)

This initiative is not subject to intergovernmental review.

6. Funding Restrictions

All NIH awards are subject to the terms and conditions, cost principles, and other considerations described in the NIH Grants Policy Statement.

Pre-award costs are allowable only as described in the NIH Grants Policy Statement Section 7.9.1 Selected Items of Cost.

Applications must be submitted electronically following the instructions described in the How to Apply Application Guide. Paper applications will not be accepted.

Applicants must complete all required registrations before the application due date. Section III. Eligibility Information contains information about registration.

For assistance with your electronic application or for more information on the electronic submission process, visit How to Apply – Application Guide. If you encounter a system issue beyond your control that threatens your ability to complete the submission process on-time, you must follow the Dealing with System Issues guidance. For assistance with application submission, contact the Application Submission Contacts in Section VII.

Important reminders:

All PD(s)/PI(s) must include their eRA Commons ID in the Credential field of the Senior/Key Person Profile form. Failure to register in the Commons and to include a valid PD/PI Commons ID in the credential field will prevent the successful submission of an electronic application to NIH. See Section III of this NOFO for information on registration requirements.

The applicant organization must ensure that the unique entity identifier provided on the application is the same identifier used in the organization’s profile in the eRA Commons and for the System for Award Management. Additional information may be found in the How to Apply Application Guide.

See more tips for avoiding common errors.

Upon receipt, applications will be evaluated for completeness and compliance with application instructions by the Center for Scientific Review, NIH. Applications that are incomplete or non-compliant will not be reviewed.

Recipients or subrecipients must submit any information related to violations of federal criminal law involving fraud, bribery, or gratuity violations potentially affecting the federal award. See Mandatory Disclosures, 2 CFR 200.113 and NIH Grants Policy Statement Section 4.1.35.

Send written disclosures to the NIH Chief Grants Management Officer listed on the Notice of Award for the IC that funded the award and to the HHS Office of Inspector Grant Self Disclosure Program at [email protected].

Post Submission Materials

Applicants are required to follow the instructions for post-submission materials, as described in the policy

Provost letters may be solicited at the sole initiative and discretion of NIH. 

Section V. Application Review Information

1. Criteria

Only the review criteria described below will be considered in the review process. Applications submitted to the NIH in support of the NIH mission are evaluated for scientific and technical merit through the NIH peer review system.

For this particular announcement, note the following:

This NOFO has three objectives: (1) provide support for meritorious research at health professional or graduate institutions or institutional components; (2) strengthen the research environment at these institutions/components; and (3) give health professional, undergraduate and/or graduate students an opportunity to gain significant biomedical research experience through active involvement in the research. 

The scientific foundation for the proposed research should be established using preliminary data (if available) and/or published data. Although preliminary data are not required for an R15 application, they may be included if available.

Health professionals in health professional schools, and/or graduate students in graduate schools, as well as undergraduate students pursuing biomedical or behavioral research, must be included in the research team. Any combination of health professional, undergraduates and/or graduate students from PIs’ institutions is allowed on the research team.

Reviewers will provide an overall impact score to reflect their assessment of the likelihood for the project to make important scientific contributions to the research field(s) involved, while providing research opportunities to [undergraduate or graduate or health professional students] and strengthening the research environment of the institution, in consideration of the following review criteria and additional review criteria (as applicable for the project proposed).

Reviewers will consider Factors 1, 2 and 3 in the determination of scientific merit, and in providing an overall impact score. In addition, Factors 1 and 2 will each receive a separate criterion score. An application does not need to be strong in all categories to be judged as a high impact R15 application. For example, a solid and interesting scientific research project that is not by its nature innovative or paradigm-shifting, and includes a good plan to engage [undergraduate or graduate or health professional students] in primary research may be considered a strong R15 application.

As applicable for the project proposed, reviewers will consider the following additional items while determining scientific and technical merit, but will not give criterion scores for these items, and should consider them in providing an overall impact score.

As applicable for the project proposed, reviewers will consider each of the following items, but will not give scores for these items, and should not consider them in providing an overall impact score.

2. Review and Selection Process

Applications will be evaluated for scientific and technical merit by (an) appropriate Scientific Review Group(s) convened by the Center for Scientific Review, in accordance with NIH peer review policy and procedures, using the stated review criteria. Assignment to a Scientific Review Group will be shown in the eRA Commons.

As part of the scientific peer review, all applications will receive a written critique.

Applications may undergo a selection process in which only those applications deemed to have the highest scientific and technical merit (generally the top half of applications under review) will be discussed and assigned an overall impact score.

Applications will be assigned on the basis of established PHS referral guidelines to the appropriate NIH Institute or Center. Applications will compete for available funds with all other recommended applications submitted in response to this NOFO. Following initial peer review, recommended applications will receive a second level of review by the appropriate national Advisory Council or Board. The following will be considered in making funding decisions:

• Scientific and technical merit of the proposed project as determined by scientific peer review.
• Availability of funds.
• Relevance of the proposed project to program priorities.
• Portfolio breadth.

If the application is under consideration for funding, NIH will request "just-in-time" information from the applicant as described in the NIH Grants Policy Statement Section 2.5.1. Just-in-Time Procedures. This request is not a Notice of Award nor should it be construed to be an indicator of possible funding.

Prior to making an award, NIH reviews an applicant’s federal award history in SAM.gov to ensure sound business practices. An applicant can review and comment on any information in the Responsibility/Qualification records available in SAM.gov. NIH will consider any comments by the applicant in the Responsibility/Qualification records in SAM.gov to ascertain the applicant’s integrity, business ethics, and performance record of managing Federal awards per 2 CFR Part 200.206 “Federal awarding agency review of risk posed by applicants.” This provision will apply to all NIH grants and cooperative agreements except fellowships.

3. Anticipated Announcement and Award Dates

After the peer review of the application is completed, the PD/PI will be able to access his or her Summary Statement (written critique) via the eRA Commons. Refer to Part 1 for dates for peer review, advisory council review, and earliest start date.

Information regarding the disposition of applications is available in the NIH Grants Policy Statement Section 2.4.4 Disposition of Applications.

Section VI. Award Administration Information

1. Award Notices

A Notice of Award (NoA) is the official authorizing document notifying the applicant that an award has been made and that funds may be requested from the designated HHS payment system or office. The NoA is signed by the Grants Management Officer and emailed to the recipient’s business official.

In accepting the award, the recipient agrees that any activities under the award are subject to all provisions currently in effect or implemented during the period of the award, other Department regulations and policies in effect at the time of the award, and applicable statutory provisions.

Recipients must comply with any funding restrictions described in Section IV.6. Funding Restrictions. Any pre-award costs incurred before receipt of the NoA are at the applicant's own risk.  For more information on the Notice of Award, please refer to the NIH Grants Policy Statement Section 5. The Notice of Award and NIH Grants & Funding website, see Award Process.

Institutional Review Board or Independent Ethics Committee Approval: Recipient institutions must ensure that protocols are reviewed by their IRB or IEC. To help ensure the safety of participants enrolled in NIH-funded studies, the recipient must provide NIH copies of documents related to all major changes in the status of ongoing protocols.

2. Administrative and National Policy Requirements

The following Federal wide and HHS-specific policy requirements apply to awards funded through NIH:

• The rules listed at 2 CFR Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards.
• All NIH grant and cooperative agreement awards include the NIH Grants Policy Statement as part of the terms and conditions in the Notice of Award (NoA). The NoA includes the requirements of this NOFO. For these terms of award, see the NIH Grants Policy Statement Part II: Terms and Conditions of NIH Grant Awards, Subpart A: General and Part II: Terms and Conditions of NIH Grant Awards, Subpart B: Terms and Conditions for Specific Types of Grants, Recipients, and Activities.
• If a recipient receives an award, the recipient must follow all applicable nondiscrimination laws. The recipient agrees to this when registering in SAM.gov. The recipient must also submit an Assurance of Compliance (HHS-690). To learn more, see the Laws and Regulations Enforced by the HHS Office for Civil Rights website.
  • HHS recognizes that NIH research projects are often limited in scope for many reasons that are nondiscriminatory, such as the principal investigator’s scientific interest, funding limitations, recruitment requirements, and other considerations. Thus, criteria in research protocols that target or exclude certain populations are warranted where nondiscriminatory justifications establish that such criteria are appropriate with respect to the health or safety of the subjects, the scientific study design, or the purpose of the research. For additional guidance regarding how the provisions apply to NIH grant programs, please contact the Scientific/Research Contact that is identified in Section VII under Agency Contacts of this NOFO.

All federal statutes and regulations relevant to federal financial assistance, including those highlighted in NIH Grants Policy Statement Section 4 Public Policy Requirements, Objectives and Other Appropriation Mandates.

Recipients are responsible for ensuring that their activities comply with all applicable federal regulations.  NIH may terminate awards under certain circumstances.  See 2 CFR Part 200.340 Termination and NIH Grants Policy Statement Section 8.5.2 Remedies for Noncompliance or Enforcement Actions: Suspension, Termination, and Withholding of Support. 

Successful recipients under this NOFO agree that:

Where the award funding involves implementing, acquiring, or upgrading health IT for activities by any funded entity, recipients and subrecipient(s) are required to: Use health IT that meets standards and implementation specifications adopted in 45 CFR part 170, Subpart B, if such standards and implementation specifications can support the activity.  Visit https://www.ecfr.gov/current/title-45/subtitle-A/subchapter-D/part-170/subpart-B to learn more.

Where the award funding involves implementing, acquiring, or upgrading health IT for activities by eligible clinicians in ambulatory settings, or hospitals, eligible under Sections 4101, 4102, and 4201 of the HITECH Act, use health IT certified under the ONC Health IT Certification Program if certified technology can support the activity. Visit https://www.healthit.gov/topic/certification-ehrs/certification-health-it to learn more.

Pursuant to the Cybersecurity Act of 2015, Div. N, § 405, Pub. Law 114-113, 6 USC § 1533(d), the HHS Secretary has established a common set of voluntary, consensus-based, and industry-led guidelines, best practices, methodologies, procedures, and processes.

Successful recipients under this NOFO agree that:

When recipients, subrecipients, or third-party entities have:

1. ongoing and consistent access to HHS owned or operated information or operational technology systems; and
2. receive, maintain, transmit, store, access, exchange, process, or utilize personal identifiable information (PII) or personal health information (PHI) obtained from the awarding HHS agency for the purposes of executing the award.

Recipients shall develop plans and procedures, modeled after the NIST Cybersecurity framework, to protect HHS systems and data. Please refer to NIH Post-Award Monitoring and Reporting for additional information. 

Not Applicable

Consistent with the 2023 NIH Policy for Data Management and Sharing, when data management and sharing is applicable to the award, recipients will be required to adhere to the Data Management and Sharing requirements as outlined in the NIH Grants Policy Statement. Upon the approval of a Data Management and Sharing Plan, it is required for recipients to implement the plan as described.

4. Reporting

Progress reports for multi-year funded awards are due annually on or before the anniversary of the budget/project period start date of award. The reporting period for multi-year funded award progress report is the calendar year preceding the anniversary date of the award. Information on the content of the progress report and instructions on how to submit the report using the RPPR are posted at http://grants.nih.gov/grants/policy/myf.htm. 

• Undergraduates have gone on to and/or graduated from graduate or health professional schools or 
• Health professionals and graduate students have research products such as publications, graduate students have transitioned to employment in the biomedical or behavioral workforce. Health professionals and graduate students who complete their degree(s) demonstrate continued research activity shown by, e.g., NIH funding as a PI, MPI, or co-investigator or other federal or non-federal support.
   

A final RPPR, invention statement, and the expenditure data portion of the Federal Financial Report are required for closeout of an award, as described in the NIH Grants Policy Statement Section 8.6 Closeout. NIH NOFOs outline intended research goals and objectives. Post award, NIH will review and measure performance based on the details and outcomes that are shared within the RPPR, as described at 2 CFR Part 200.301.

In carrying out stewardship of grant programs, NIH will periodically evaluate the REAP R15 program, employing the representative measures identified below. In assessing the effectiveness of research project grant investments, NIH may use information from progress reports and public databases, PDs/PIs, and from participants themselves. Where necessary, PDs/PIs and participants may be appropriately contacted after the completion of the grant period for updates on participants’ subsequent outcomes.

The overall evaluation of the program will be based on metrics that may include, but are not limited to, the following:

Characteristics of the applicant and awardee pool for the program, such as:

• Geographic distribution
• Investigator demographics
• Health professional, undergraduate student researcher and/or graduate student demographics
• Institution types
• Scientific topics of supported research

Indicators of scientific accomplishments/productivity, such as:

• Outcomes for health professionals, undergraduate student researchers and/or graduate students  
• Effects on the institution’s research environment
• Peer-reviewed research publications and citations
• Presentations at scientific conferences (talks, posters, etc.)
• Patent activity among grantees

Section VII. Agency Contacts

We encourage inquiries concerning this funding opportunity and welcome the opportunity to answer questions from potential applicants.

eRA Service Desk (Questions regarding ASSIST, eRA Commons, application errors and warnings, documenting system problems that threaten submission by the due date, and post-submission issues)

Finding Help Online: https://www.era.nih.gov/need-help (preferred method of contact)
Telephone: 301-402-7469 or 866-504-9552 (Toll Free)

General Grants Information (Questions regarding application instructions, application processes, and NIH grant resources)
Email: [email protected] (preferred method of contact)
Telephone: 301-480-7075

Grants.gov Customer Support (Questions regarding Grants.gov registration and Workspace)
Contact Center Telephone: 800-518-4726
Email: [email protected]

Lorena Baccaglini, D.D.S., M.S., Ph.D.
National Institute of Dental and Craniofacial Research (NIDCR)
Phone: (301) 435-7908
Email: [email protected]

Susan L Sullivan
NIDCD - NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS
Phone: 301-496-8683
E-mail: [email protected]

Astrid Haugen, PhD
NIEHS - National Institute of Environmental Health Sciences
Phone: 984-287-3266 or 919-328-0155
Email: [email protected]

Letitia Alexis Weigand
NINDS - NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE
Phone: 301-451-7968
E-mail: [email protected]

Biman C. Paria, Ph.D., MS (Reg. Sc)
National Cancer Institute (NCI)
Email: [email protected]

Jasenka Borzan, PhD
National Institute of Mental Health (NIMH)
Phone: 667-900-1640
Email: [email protected]

Lisa Chadwick
NHGRI - NATIONAL HUMAN GENOME RESEARCH INSTITUTE
Phone: 301-435-7275
E-mail: [email protected]

Cheri Wiggs
NEI - NATIONAL EYE INSTITUTE
Phone: (301) 402-0276
E-mail: [email protected]

Karen Marie McNamara, PhD
National Institute of Nursing Research (NINR)
Telephone: 301-337-1372
Email: [email protected]
 

NIAID Training Help Desk
National Institute of Allergy and Infectious Diseases (NIAID)
Telephone: 301-594-5945
Email: [email protected] 

Rene Etcheberrigaray, M.D.
National Institute on Aging (NIA)
Phone: 301-451-9798
Email: [email protected]

Aaron D. Laposky, PhD
National Heart, Lung, Blood Institute (NHLBI)
Telephone: (301) 827-7837
Email: [email protected]

Li Lin, Ph.D.
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Phone: 301-827-7749
E-mail: [email protected]

David Joseph Gutekunst
NIBIB - NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING
Phone: (301) 402-5069
E-mail: [email protected]

Miguel A. Contreras, Ph.D.
Office of Research Infrastructure Programs (ORIP)
Phone: 301-594-9410
E-mail: [email protected]

Yuki Lama
NIDA - NATIONAL INSTITUTE ON DRUG ABUSE
Phone: (301) 402-4781
E-mail: [email protected]

Lanay M. Mudd, Ph.D.
National Center for Complementary and Integrative Health (NCCIH)
Phone: 301-594-9346
Email: [email protected]

Kristy Nicks, PhD
NIAMS - NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES
Phone: (301) 594-5055
E-mail: [email protected]

Mahua Mukhopadhyay, PhD
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Telephone: 301- 435-6886
Email: [email protected]

Examine your eRA Commons account for review assignment and contact information (information appears two weeks after the submission due date).

General R15-Related Review Questions:

Svetlana E. Kotliarova, PhD
Center for Scientific Review (CSR)
Telephone: 301-594-7945
Email: [email protected]

Gabriel Hidalgo
National Institute of Dental and Craniofacial Research (NIDCR)
Phone: 301-827-4630
E-mail: [email protected]

Samantha J Tempchin
NIDCD - NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS
Phone: (301) 435-1404
E-mail: [email protected]

Jenny Greer
NIEHS - National Institute of Environmental Health Sciences
Phone: 984-287-3332 or 919-892-4180
Email: [email protected]

Chief Grants Management Officer
National Institute of Neurological Disorders and Stroke (NINDS)
Email:[email protected]

Crystal Wolfrey
National Cancer Institute (NCI)
Telephone: 240-276-6277
Email: [email protected]

Terri Jarosik
National Institute of Mental Health (NIMH)
Telephone: 301-443-3858
Email: [email protected]

Deanna L Ingersoll
NHGRI - NATIONAL HUMAN GENOME RESEARCH INSTITUTE
Phone: 301-435-7858
E-mail: [email protected]

Karen Robinson Smith
NEI - NATIONAL EYE INSTITUTE
Phone: 301-435-8178
E-mail: [email protected]

Ron Wertz
National Institute of Nursing Research (NINR)
Telephone: 301-594-2807
Email: [email protected]
 

Abbie Gerhart
National Institute of Allergy and Infectious Diseases (NIAID)   
Telephone: 240-669-5091
Email: [email protected]

Ryan Blakeney
National Institute on Aging (NIA)
Phone: 301-451-9802
Email: [email protected]

Anthony Agresti
NHLBI - NATIONAL HEART, LUNG, AND BLOOD INSTITUTE
Phone: 301-827-8014
E-mail: [email protected]

Judy Fox
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Telephone: 301-443-4704
Email: [email protected]

Pamela G Fleming
NIDA - NATIONAL INSTITUTE ON DRUG ABUSE
Phone: 301-480-1159
E-mail: [email protected]

Debbie Chen
National Center for Complementary and Integrative Health (NCCIH)
Phone: 301-594-3788
Email: [email protected]

Teresa Do
NIAMS - NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES
Phone: (301) 594-3512
E-mail: [email protected]

Margaret Young
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Telephone: 301-642-4552
Email: [email protected]

Section VIII. Other Information

Recently issued trans-NIH policy notices may affect your application submission. A full list of policy notices published by NIH is provided in the NIH Guide for Grants and Contracts. All awards are subject to the terms and conditions, cost principles, and other considerations described in the NIH Grants Policy Statement.

Awards are made under the authorization of Sections 301 and 405 of the Public Health Service Act as amended (42 USC 241 and 284) and under Federal Regulations 42 CFR Part 52 and 2 CFR Part 200.